Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7164 p313-316
8 September 2001

This article
Reprint
Photocopy


News summary


Review suggests trying ginkgo for dementia

Ginkgo biloba has a small but significant effect on the symptoms of dementia, according to a review of clinical trials involving the drug.

Ian Maidment, principal pharmacist for mental health at East Kent Community NHS Trust, who conducted the review, says that it is an interesting agent, which might have effects comparable to those of acetylcholinesterase inhibitors.

Mr Maidment says that the mode of action and correct dose of ginkgo for the treatment of dementia has yet to be established but that it seems to be relatively free from side effects. However, it is thought to have anticoagulant effects and, therefore, should be used with caution in patients receiving other anticoagulant drugs. In addition, trials are needed to establish whether it works synergistically or interacts adversely with acetylcholinesterase inhibitors.

When asked what he would tell patients seeking advice on whether they should try ginkgo, Mr Maidment said: “I’d say that I would take it if I had dementia, because dementia is such a debilitating disease and there are few treatments for it. There is little to lose, so it would definitely be worth a try. It is difficult to know what to advise patients about taking ginkgo with acetylcholinesterase inhibitors when there is so little data about interactions, but I personally would try it.” (Psychiatric Bulletin 2001;25:353–6.)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal